Research progress on pyroptosis-mediated immune-inflammatory response in ischemic stroke and the role of natural plant components as regulator of pyroptosis: A review.

[1]  Xiaojuan Zhang,et al.  A potential new pathway for heparin treatment of sepsis-induced lung injury: inhibition of pulmonary endothelial cell pyroptosis by blocking hMGB1-LPS-induced caspase-11 activation , 2022, Frontiers in Cellular and Infection Microbiology.

[2]  Liuting Zeng,et al.  The mechanism of ferroptosis regulating oxidative stress in ischemic stroke and the regulation mechanism of natural pharmacological active components. , 2022, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[3]  S. Luo,et al.  Ferroptosis and Autoimmune Diseases , 2022, Frontiers in Immunology.

[4]  Shangqin Chen,et al.  Simvastatin Inhibits NLRP3 Inflammasome Activation and Ameliorates Lung Injury in Hyperoxia-Induced Bronchopulmonary Dysplasia via the KLF2-Mediated Mechanism , 2022, Oxidative medicine and cellular longevity.

[5]  K. Fu,et al.  Non-apoptotic cell death in ovarian cancer: Treatment, resistance and prognosis. , 2022, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[6]  Dongyi Zhao,et al.  Mechanism of cell death pathways in status epilepticus and related therapeutic agents. , 2022, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[7]  Kailin Yang,et al.  Uncovering the Neuroprotective Effect of Hedysarum multijugum Maxim-Chuanxiong Rhizoma Compound on Cerebral Infarction through Quantitative Proteomics , 2022, Evidence-based complementary and alternative medicine : eCAM.

[8]  M. Mackay,et al.  Childhood Stroke , 2020, Clinical Child Neurology.

[9]  Yibin Jia,et al.  HBO Alleviates Neural Stem Cell Pyroptosis via lncRNA-H19/miR-423-5p/NLRP3 Axis and Improves Neurogenesis after Oxygen Glucose Deprivation , 2022, Oxidative medicine and cellular longevity.

[10]  V. Feigin,et al.  World Stroke Organization (WSO): Global Stroke Fact Sheet 2022 , 2022, International journal of stroke : official journal of the International Stroke Society.

[11]  Yun Wei,et al.  Neuronal injuries in cerebral infarction and ischemic stroke: From mechanisms to treatment (Review) , 2021, International journal of molecular medicine.

[12]  Yanwei Xing,et al.  Targeting Ferroptosis: Pathological Mechanism and Treatment of Ischemia-Reperfusion Injury , 2021, Oxidative medicine and cellular longevity.

[13]  V. Hornung,et al.  Inflammasomes in T cells. , 2021, Journal of molecular biology.

[14]  V. Rathinam,et al.  Mechanisms and Consequences of Noncanonical Inflammasome-Mediated Pyroptosis. , 2021, Journal of molecular biology.

[15]  P. Sun,et al.  Targeting NLRP3 Inflammasome in Translational Treatment of Nervous System Diseases: An Update , 2021, Frontiers in Pharmacology.

[16]  Chen Jiang,et al.  Macrophage‐Disguised Manganese Dioxide Nanoparticles for Neuroprotection by Reducing Oxidative Stress and Modulating Inflammatory Microenvironment in Acute Ischemic Stroke , 2021, Advanced science.

[17]  Linxi Chen,et al.  Targetting ferroptosis for blood cell-related diseases , 2021, Journal of drug targeting.

[18]  Chang-Qing Deng,et al.  Effect of the combination of astragaloside IV and Panax notoginseng saponins on pyroptosis and necroptosis in rat models of cerebral ischemia-reperfusion , 2021, Experimental and therapeutic medicine.

[19]  L. Kalinowski,et al.  Nitric Oxide-Dependent Pathways as Critical Factors in the Consequences and Recovery after Brain Ischemic Hypoxia , 2021, Biomolecules.

[20]  Liuting Zeng,et al.  Exploring the Regulatory Mechanism of Hedysarum Multijugum Maxim.-Chuanxiong Rhizoma Compound on HIF-VEGF Pathway and Cerebral Ischemia-Reperfusion Injury’s Biological Network Based on Systematic Pharmacology , 2021, Frontiers in Pharmacology.

[21]  G. Tsivgoulis,et al.  Inflammation and Stroke Risk: A New Target for Prevention. , 2021, Stroke.

[22]  M. Fischbach,et al.  Gut microbes impact stroke severity via the trimethylamine N-oxide pathway. , 2021, Cell host & microbe.

[23]  M. Aschner,et al.  New epigenetic players in stroke pathogenesis: From non-coding RNAs to exosomal non-coding RNAs , 2021, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[24]  P. Lei,et al.  Mechanisms of neuronal cell death in ischemic stroke and their therapeutic implications , 2021, Medicinal research reviews.

[25]  Yunman Li,et al.  Pyroptosis in stroke-new insights into disease mechanisms and therapeutic strategies , 2021, Journal of Physiology and Biochemistry.

[26]  Hua Zhu,et al.  Gasdermin D in pyroptosis , 2021, Acta pharmaceutica Sinica. B.

[27]  Fei Li,et al.  Medioresinol as a novel PGC-1α activator prevents pyroptosis of endothelial cells in ischemic stroke through PPARα-GOT1 axis. , 2021, Pharmacological research.

[28]  Sheng-Mei Zhu,et al.  LncRNA-Fendrr protects against the ubiquitination and degradation of NLRC4 protein through HERC2 to regulate the pyroptosis of microglia , 2021, Molecular medicine.

[29]  Bo Ouyang,et al.  Gastrodin Alleviates Cerebral Ischaemia/Reperfusion Injury by Inhibiting Pyroptosis by Regulating the lncRNA NEAT1/miR-22-3p Axis , 2021, Neurochemical Research.

[30]  Xiang Chen,et al.  Pyroptosis: mechanisms and diseases , 2021, Signal Transduction and Targeted Therapy.

[31]  Mao-Tao He,et al.  Uncoupling Protein 2 Deficiency Enhances NLRP3 Inflammasome Activation Following Hyperglycemia-Induced Exacerbation of Cerebral Ischemia and Reperfusion Damage In Vitro and In Vivo , 2021, Neurochemical Research.

[32]  Yilei Zhang,et al.  Bone marrow mesenchymal stem cell-derived exosomes attenuate cerebral ischemia-reperfusion injury-induced neuroinflammation and pyroptosis by modulating microglia M1/M2 phenotypes , 2021, Experimental Neurology.

[33]  J. Payandeh,et al.  Discovery of a caspase cleavage motif antibody reveals insights into noncanonical inflammasome function , 2021, Proceedings of the National Academy of Sciences.

[34]  Ya-Shuo Feng,et al.  The involvement of NLRP3 inflammasome in the treatment of neurodegenerative diseases. , 2021, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[35]  Peiying Yang,et al.  Molecular mechanisms of astragaloside‑IV in cancer therapy (Review). , 2021, International journal of molecular medicine.

[36]  D. Yellon,et al.  Does remote ischaemic conditioning reduce inflammation? A focus on innate immunity and cytokine response , 2021, Basic Research in Cardiology.

[37]  Y. Leng,et al.  MircoRNA-29a in Astrocyte-derived Extracellular Vesicles Suppresses Brain Ischemia Reperfusion Injury via TP53INP1 and the NF-κB/NLRP3 Axis , 2021, Cellular and Molecular Neurobiology.

[38]  Samraj Sinha,et al.  Manipulation of Inflammasome: A Promising Approach Towards Immunotherapy of Lung Cancer , 2021, International reviews of immunology.

[39]  Ping Yang,et al.  Chaihu-Longgu-Muli Decoction Exerts an Antiepileptic Effect in Rats by Improving Pyroptosis in Hippocampal Neurons. , 2021, Journal of ethnopharmacology.

[40]  N. Zhang,et al.  Salvianolic Acids for Injection Alleviates Cerebral Ischemia/Reperfusion Injury by Switching M1/M2 Phenotypes and Inhibiting NLRP3 Inflammasome/Pyroptosis Axis in Microglia In Vivo and In Vitro. , 2021, Journal of ethnopharmacology.

[41]  Liang Gao,et al.  CHRFAM7A Overexpression Attenuates Cerebral Ischemia-Reperfusion Injury via Inhibiting Microglia Pyroptosis Mediated by the NLRP3/Caspase-1 pathway , 2021, Inflammation.

[42]  H. Takeda,et al.  Microglial metabolic disturbances and neuroinflammation in cerebral infarction. , 2021, Journal of pharmacological sciences.

[43]  Z. Qin,et al.  TP53-induced glycolysis and apoptosis regulator alleviates hypoxia/ischemia-induced microglial pyroptosis and ischemic brain damage , 2020, Neural regeneration research.

[44]  D. Vivien,et al.  Filling the gaps on stroke research: Focus on inflammation and immunity , 2020, Brain, Behavior, and Immunity.

[45]  S. Allan,et al.  Cardiovascular comorbidities, inflammation, and cerebral small vessel disease , 2021 .

[46]  Yanshi Wang,et al.  NLRP3 Inflammasome and Its Critical Role in Gynecological Disorders and Obstetrical Complications , 2021, Frontiers in Immunology.

[47]  M. Huang,et al.  Inhibition of Caspase-1 Ameliorates Ischemia-Associated Blood-Brain Barrier Dysfunction and Integrity by Suppressing Pyroptosis Activation , 2021, Frontiers in Cellular Neuroscience.

[48]  Junping Zhang,et al.  Neuroinflammation in Ischemic Stroke: Focus on MicroRNA-mediated Polarization of Microglia , 2021, Frontiers in Molecular Neuroscience.

[49]  Wusheng Zhu,et al.  Low-density lipoprotein receptor (LDLR) regulates NLRP3-mediated neuronal pyroptosis following cerebral ischemia/reperfusion injury , 2020, Journal of neuroinflammation.

[50]  Jianliang Zhang,et al.  Panax notoginseng saponins and their applications in nervous system disorders: a narrative review , 2020, Annals of translational medicine.

[51]  Xiaohui Fan,et al.  Chemical constituents of Panax ginseng and Panax notoginseng explain why they differ in therapeutic efficacy. , 2020, Pharmacological research.

[52]  T. Arumugam,et al.  CD137 Ligand-CD137 Interaction is Required For Inflammasome-Associated Brain Injury Following Ischemic Stroke , 2020, NeuroMolecular Medicine.

[53]  Yunman Li,et al.  Targeting pyroptosis to regulate ischemic stroke injury: Molecular mechanisms and preclinical evidences , 2020, Brain Research Bulletin.

[54]  Liuting Zeng,et al.  The Effect of Hedysarum multijugum Maxim.-Chuanxiong rhizoma Compound on Ischemic Stroke: A Research Based on Network and Experimental Pharmacology , 2020, Oxidative medicine and cellular longevity.

[55]  Dong-Sun Han,et al.  The role of peripheral monocytes and macrophages in ischemic stroke , 2020, Neurological Sciences.

[56]  M. Dimitrova,et al.  Stroke and the immune system: A review of the new strategies. , 2020, Folia medica.

[57]  Tao Yu,et al.  NLRP3 inflammasome in endothelial dysfunction , 2020, Cell Death & Disease.

[58]  A. Tuttolomondo,et al.  Neuroinflammatory Mechanisms in Ischemic Stroke: Focus on Cardioembolic Stroke, Background, and Therapeutic Approaches , 2020, International journal of molecular sciences.

[59]  A. Doroszko,et al.  Role of the Platelets and Nitric Oxide Biotransformation in Ischemic Stroke: A Translative Review from Bench to Bedside , 2020, Oxidative medicine and cellular longevity.

[60]  Yu-Sheng Zhang,et al.  TREM-1-targeting LP17 attenuates cerebral ischemia-induced neuronal injury by inhibiting oxidative stress and pyroptosis. , 2020, Biochemical and biophysical research communications.

[61]  S. Shaffer,et al.  Succination inactivates gasdermin D and blocks pyroptosis , 2020, Science.

[62]  Guoying Zhou,et al.  Role of the neurovascular unit in the process of cerebral ischemic injury. , 2020, Pharmacological research.

[63]  L. Bi,et al.  Role of the NLRP3 inflammasome in autoimmune diseases. , 2020, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[64]  R. Rodrigo,et al.  Pathophysiology of ischemic stroke: role of oxidative stress. , 2020, Current pharmaceutical design.

[65]  Bowen Zhou,et al.  Caspase-1 Engages Full-Length Gasdermin D through Two Distinct Interfaces That Mediate Caspase Recruitment and Substrate Cleavage. , 2020, Immunity.

[66]  Y. Zhang,et al.  Occludin degradation makes brain microvascular endothelial cells more vulnerable to reperfusion injury in vitro , 2020, Journal of neurochemistry.

[67]  T. Nyman,et al.  Function and Regulation of Noncanonical Caspase-4/5/11 Inflammasome , 2020, The Journal of Immunology.

[68]  Zhiping Hu,et al.  Hypoxia-preconditioned olfactory mucosa mesenchymal stem cells abolish cerebral ischemia/reperfusion-induced pyroptosis and apoptotic death of microglial cells by activating HIF-1α , 2020, Aging.

[69]  Ming-Tsan Lin,et al.  Intravenous Arginine Administration Downregulates NLRP3 Inflammasome Activity and Attenuates Acute Kidney Injury in Mice with Polymicrobial Sepsis , 2020, Mediators of inflammation.

[70]  Shanshan Liu,et al.  Oxidative stress induced pyroptosis leads to osteogenic dysfunction of MG63 cells , 2020, Journal of Molecular Histology.

[71]  Zhi-yuan Yu,et al.  Caspase‐1 inhibition prevents neuronal death by targeting the canonical inflammasome pathway of pyroptosis in a murine model of cerebral ischemia , 2020, CNS neuroscience & therapeutics.

[72]  P. Lei,et al.  The pathological role of ferroptosis in ischemia/reperfusion-related injury , 2020, Zoological research.

[73]  T. Shichita,et al.  Lipid mediators and sterile inflammation in ischemic stroke. , 2020, International immunology.

[74]  Xia Li,et al.  Adiponectin peptide alleviates oxidative stress and NLRP3 inflammasome activation after cerebral ischemia-reperfusion injury by regulating AMPK/GSK-3β , 2020, Experimental Neurology.

[75]  Lihua Wang,et al.  Inhibition of double‐strand DNA‐sensing cGAS ameliorates brain injury after ischemic stroke , 2020, EMBO molecular medicine.

[76]  K. Furie.  Epidemiology and Primary Prevention of Stroke. , 2020, Continuum.

[77]  D. Yavagal,et al.  Cell Death Pathways in Ischemic Stroke and Targeted Pharmacotherapy , 2020, Translational Stroke Research.

[78]  Weidong Zhang,et al.  An updated role of astragaloside IV in heart failure. , 2020, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[79]  John H. Zhang,et al.  Glial Cells: Role of the Immune Response in Ischemic Stroke , 2020, Frontiers in Immunology.

[80]  J. Zhao,et al.  NLRP6 expressed in astrocytes aggravates neurons injury after OGD/R through activating the inflammasome and inducing pyroptosis. , 2020, International immunopharmacology.

[81]  Xiao-ying Wang,et al.  The HDAC3 inhibitor RGFP966 ameliorated ischemic brain damage by downregulating the AIM2 inflammasome , 2020, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[82]  Qiang Wang,et al.  Long non-coding RNA MEG3 promotes cerebral ischemia-reperfusion injury through increasing pyroptosis by targeting miR-485/AIM2 axis , 2019, Experimental Neurology.

[83]  X. Qin,et al.  Astragaloside IV derived from Astragalus membranaceus: A research review on the pharmacological effects. , 2020, Advances in pharmacology.

[84]  Dong He,et al.  Long non-coding RNAs and pyroptosis. , 2019, Clinica chimica acta; international journal of clinical chemistry.

[85]  G. López-Castejón.  Control of the inflammasome by the ubiquitin system , 2019, The FEBS journal.

[86]  Xi Wu,et al.  Pyroptosis: A new frontier in cancer. , 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[87]  Qiongxiu Zhou,et al.  Mitochondria as a therapeutic target for ischemic stroke. , 2019, Free radical biology & medicine.

[88]  Yuan Cai,et al.  Neuroprotective effect of glycosides in Buyang Huanwu Decoction on pyroptosis following cerebral ischemia-reperfusion injury in rats. , 2019, Journal of ethnopharmacology.

[89]  V. Ten,et al.  Mechanism of mitochondrial complex I damage in brain ischemia/reperfusion injury. A hypothesis , 2019, Molecular and Cellular Neuroscience.

[90]  J. Xie,et al.  Hispidulin exhibits neuroprotective activities against cerebral ischemia reperfusion injury through suppressing NLRP3-mediated pyroptosis. , 2019, Life sciences.

[91]  Ping Yang,et al.  Gastrodin ameliorates microvascular reperfusion injury–induced pyroptosis by regulating the NLRP3/caspase-1 pathway , 2019, Journal of Physiology and Biochemistry.

[92]  Weifeng Yu,et al.  Potential Immunotherapeutic Targets on Myeloid Cells for Neurovascular Repair After Ischemic Stroke , 2019, Front. Neurosci..

[93]  J. Roda,et al.  Early toll‐like receptor 4 blockade reduces ROS and inflammation triggered by microglial pro‐inflammatory phenotype in rodent and human brain ischaemia models , 2019, British journal of pharmacology.

[94]  Gelin Xu,et al.  Microglial TREM-1 receptor mediates neuroinflammatory injury via interaction with SYK in experimental ischemic stroke , 2019, Cell Death & Disease.

[95]  V. Kumar,et al.  Toll-like receptors in the pathogenesis of neuroinflammation , 2019, Journal of Neuroimmunology.

[96]  Jing Zhao,et al.  Effects of NLRP6 in Cerebral Ischemia/Reperfusion (I/R) Injury in Rats , 2019, Journal of Molecular Neuroscience.

[97]  Yuan He,et al.  The NLRP3 Inflammasome: An Overview of Mechanisms of Activation and Regulation , 2019, International journal of molecular sciences.

[98]  Yu Feng,et al.  Non‐coding RNA involvement in the pathogenesis of diabetic cardiomyopathy , 2019, Journal of cellular and molecular medicine.

[99]  Yunman Li,et al.  JLX001 Modulated the Inflammatory Reaction and Oxidative Stress in pMCAO Rats via Inhibiting the TLR2/4-NF-κB Signaling Pathway , 2019, Neurochemical Research.

[100]  Zhi-Jian You,et al.  NLRP3 inflammasome as a potential treatment in ischemic stroke concomitant with diabetes , 2019, Journal of Neuroinflammation.

[101]  Z. Yao,et al.  miR-21 promotes NLRP3 inflammasome activation to mediate pyroptosis and endotoxic shock , 2019, Cell Death & Disease.

[102]  Qing-long Ai,et al.  Gastrodin pretreatment alleviates rat brain injury caused by cerebral ischemic-reperfusion , 2019, Brain Research.

[103]  Lihua Wang,et al.  Caspase-1 inhibition mediates neuroprotection in experimental stroke by polarizing M2 microglia/macrophage and suppressing NF-κB activation. , 2019, Biochemical and biophysical research communications.

[104]  Erping Long,et al.  LncRNA H19 initiates microglial pyroptosis and neuronal death in retinal ischemia/reperfusion injury , 2019, Cell Death & Differentiation.

[105]  P. Vandenabeele,et al.  The molecular machinery of regulated cell death , 2019, Cell Research.

[106]  Ming Liu,et al.  Stroke in China: advances and challenges in epidemiology, prevention, and management , 2019, The Lancet Neurology.

[107]  Zan Huang,et al.  Mitochondrial ROS promote macrophage pyroptosis by inducing GSDMD oxidation , 2019, Journal of molecular cell biology.

[108]  Y. Leng,et al.  Lipopolysaccharide (LPS) Aggravates High Glucose- and Hypoxia/Reoxygenation-Induced Injury through Activating ROS-Dependent NLRP3 Inflammasome-Mediated Pyroptosis in H9C2 Cardiomyocytes , 2019, Journal of diabetes research.

[109]  Huanwen Chen,et al.  Role of pyroptosis in cardiovascular diseases. , 2019, International immunopharmacology.

[110]  S. Doré,et al.  Neuroinflammatory mechanisms of blood-brain barrier damage in ischemic stroke. , 2019, American journal of physiology. Cell physiology.

[111]  T. Arumugam,et al.  Evidence that NLRC4 inflammasome mediates apoptotic and pyroptotic microglial death following ischemic stroke , 2019, Brain, Behavior, and Immunity.

[112]  A. Letai,et al.  Regulation of apoptosis in health and disease: the balancing act of BCL-2 family proteins , 2019, Nature Reviews Molecular Cell Biology.

[113]  T. Numata,et al.  Roles of volume-regulatory anion channels, VSOR and Maxi-Cl, in apoptosis, cisplatin resistance, necrosis, ischemic cell death, stroke and myocardial infarction. , 2019, Current topics in membranes.

[114]  C. Reis,et al.  NLRP3 Inflammasome in the Pathophysiology of Hemorrhagic Stroke: A Review , 2019, Current neuropharmacology.

[115]  Yunlong Bai,et al.  LncRNA KCNQ1OT1 Mediates Pyroptosis in Diabetic Cardiomyopathy , 2018, Cellular Physiology and Biochemistry.

[116]  P. Tsao,et al.  H19 Induces Abdominal Aortic Aneurysm Development and Progression , 2018, Circulation.

[117]  H. Feng,et al.  P2X7 Receptor-Associated Programmed Cell Death in the Pathophysiology of Hemorrhagic Stroke , 2018, Current neuropharmacology.

[118]  Y. Gürsoy-Özdemir,et al.  Cell Death Mechanisms in Stroke and Novel Molecular and Cellular Treatment Options , 2018, Current neuropharmacology.

[119]  K. Duris,et al.  The Role of Inflammatory Response in Stroke Associated Programmed Cell Death , 2018, Current neuropharmacology.

[120]  Feng Yan,et al.  Synergistic Interaction Between Zinc and Reactive Oxygen Species Amplifies Ischemic Brain Injury in Rats , 2018, Stroke.

[121]  K. Tan,et al.  Epidemiology, aetiology, and management of ischaemic stroke in young adults , 2018, The Lancet Neurology.

[122]  Ying Peng,et al.  Mitochondrial dysfunction induces NLRP3 inflammasome activation during cerebral ischemia/reperfusion injury , 2018, Journal of Neuroinflammation.

[123]  Zhengyu He,et al.  NLRP3/ASC-mediated alveolar macrophage pyroptosis enhances HMGB1 secretion in acute lung injury induced by cardiopulmonary bypass , 2018, Laboratory Investigation.

[124]  Giou-Teng Yiang,et al.  Current Mechanistic Concepts in Ischemia and Reperfusion Injury , 2018, Cellular Physiology and Biochemistry.

[125]  S. Nasoohi,et al.  Inhibition of the NLRP3-inflammasome as a potential approach for neuroprotection after stroke , 2018, Scientific Reports.

[126]  A. Tolkovsky,et al.  Neuronal Cell Death. , 2018, Physiological reviews.

[127]  Guibo Sun,et al.  Panax Notoginseng Saponins: A Review of Its Mechanisms of Antidepressant or Anxiolytic Effects and Network Analysis on Phytochemistry and Pharmacology , 2018, Molecules.

[128]  Guibo Sun,et al.  Inhibiting the NLRP3 Inflammasome Activation with MCC950 Ameliorates Diabetic Encephalopathy in db/db Mice , 2018, Molecules.

[129]  Fu-Liang Zhang,et al.  Free Radical Damage in Ischemia-Reperfusion Injury: An Obstacle in Acute Ischemic Stroke after Revascularization Therapy , 2018, Oxidative medicine and cellular longevity.

[130]  Wei Wang,et al.  Caspase-1-Mediated Pyroptosis of the Predominance for Driving CD4$$^{+}$$+ T Cells Death: A Nonlocal Spatial Mathematical Model , 2018, Bulletin of mathematical biology.

[131]  Bo-yu Xue,et al.  miRNA-223-3p regulates NLRP3 to promote apoptosis and inhibit proliferation of hep3B cells , 2017, Experimental and therapeutic medicine.

[132]  Yingying Zhang,et al.  Plasma membrane changes during programmed cell deaths , 2017, Cell Research.

[133]  Si Ming Man,et al.  Molecular mechanisms of inflammasome signaling , 2017, Journal of leukocyte biology.

[134]  V. Moresi,et al.  Peroxynitrite Activates the NLRP3 Inflammasome Cascade in SOD1(G93A) Mouse Model of Amyotrophic Lateral Sclerosis , 2018, Molecular Neurobiology.

[135]  T. Arumugam,et al.  Evidence that NF-κB and MAPK Signaling Promotes NLRP Inflammasome Activation in Neurons Following Ischemic Stroke , 2017, Molecular Neurobiology.

[136]  S. Lipton,et al.  Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018 , 2018, Cell Death & Differentiation.

[137]  Jie Ying Gao,et al.  MicroRNA-1906, a Novel Regulator of Toll-Like Receptor 4, Ameliorates Ischemic Injury after Experimental Stroke in Mice , 2017, The Journal of Neuroscience.

[138]  N. Sims,et al.  Reactive astrogliosis in stroke: Contributions of astrocytes to recovery of neurological function , 2017, Neurochemistry International.

[139]  David V. Hansen,et al.  TREM2, Microglia, and Neurodegenerative Diseases. , 2017, Trends in molecular medicine.

[140]  Lorenzo Galluzzi,et al.  Pharmacological modulation of autophagy: therapeutic potential and persisting obstacles , 2017, Nature Reviews Drug Discovery.

[141]  Wenqing Gao,et al.  Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin , 2017, Nature.

[142]  E. Dueber,et al.  Recent Insights into the Molecular Mechanisms Underlying Pyroptosis and Gasdermin Family Functions. , 2017, Trends in immunology.

[143]  Wenqing Gao,et al.  Pyroptosis: Gasdermin-Mediated Programmed Necrotic Cell Death. , 2017, Trends in biochemical sciences.

[144]  Qi-Hui Zhou,et al.  Astragaloside IV for Experimental Focal Cerebral Ischemia: Preclinical Evidence and Possible Mechanisms , 2017, Oxidative medicine and cellular longevity.

[145]  Jun Chen,et al.  Cerebral Vascular Disease and Neurovascular Injury in Ischemic Stroke , 2017, Circulation research.

[146]  M. Kohzuki,et al.  Clinical Evidence of Exercise Benefits for Stroke. , 2017, Advances in experimental medicine and biology.

[147]  Liangyu Zhang,et al.  Nrf2/ARE pathway inhibits ROS-induced NLRP3 inflammasome activation in BV2 cells after cerebral ischemia reperfusion , 2017, Inflammation Research.

[148]  C. Van Waes,et al.  Therapeutic Small Molecules Target Inhibitor of Apoptosis Proteins in Cancers with Deregulation of Extrinsic and Intrinsic Cell Death Pathways , 2016, Clinical Cancer Research.

[149]  M. Scott,et al.  Caspase‐1 as a multifunctional inflammatory mediator: noncytokine maturation roles , 2016, Journal of leukocyte biology.

[150]  J. An,et al.  NLRP2 is highly expressed in a mouse model of ischemic stroke. , 2016, Biochemical and biophysical research communications.

[151]  J. E. Lee,et al.  Inflammation after Ischemic Stroke: The Role of Leukocytes and Glial Cells , 2016, Experimental neurobiology.

[152]  Yi Wang,et al.  Pyroptosis is driven by non-selective gasdermin-D pore and its morphology is different from MLKL channel-mediated necroptosis , 2016, Cell Research.

[153]  T. Hasegawa,et al.  Nuclear DNA damage-triggered NLRP3 inflammasome activation promotes UVB-induced inflammatory responses in human keratinocytes. , 2016, Biochemical and biophysical research communications.

[154]  H. Stahlberg,et al.  GSDMD membrane pore formation constitutes the mechanism of pyroptotic cell death , 2016, The EMBO journal.

[155]  J. Lieberman,et al.  Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores , 2016, Nature.

[156]  K. Fitzgerald,et al.  Inflammasome Complexes: Emerging Mechanisms and Effector Functions , 2016, Cell.

[157]  W. Foo,et al.  The NLRP3 Inflammasome Mediates Inflammation Produced by Bladder Outlet Obstruction. , 2016, The Journal of urology.

[158]  A. Bitto,et al.  ROS-Mediated NLRP3 Inflammasome Activation in Brain, Heart, Kidney, and Testis Ischemia/Reperfusion Injury , 2016, Oxidative medicine and cellular longevity.

[159]  Irati Markuerkiaga,et al.  Imaging the role of toll-like receptor 4 on cell proliferation and inflammation after cerebral ischemia by positron emission tomography , 2016, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[160]  J. Chai,et al.  Structural Mechanisms in NLR Inflammasome Assembly and Signaling. , 2016, Current topics in microbiology and immunology.

[161]  N. Cheong,et al.  The NLRP3 inflammasome is critically involved in the development of bronchopulmonary dysplasia , 2015, Nature Communications.

[162]  G. Núñez,et al.  Caspase-11 Requires the Pannexin-1 Channel and the Purinergic P2X7 Pore to Mediate Pyroptosis and Endotoxic Shock. , 2015, Immunity.

[163]  Guohua Li,et al.  Protection of the brain following cerebral ischemia through the attenuation of PARP-1-induced neurovascular unit damage in rats , 2015, Brain Research.

[164]  S. Kummerfeld,et al.  Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling , 2015, Nature.

[165]  T. Cai,et al.  Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death , 2015, Nature.

[166]  D. Rossi.  Astrocyte physiopathology: At the crossroads of intercellular networking, inflammation and cell death , 2015, Progress in Neurobiology.

[167]  Si Ming Man,et al.  Regulation of inflammasome activation , 2015, Immunological reviews.

[168]  M. Khaniani,et al.  Molecular mechanisms of apoptosis and roles in cancer development and treatment. , 2015, Asian Pacific journal of cancer prevention : APJCP.

[169]  Y. Qu,et al.  Nitric oxide synthase in hypoxic or ischemic brain injury , 2015, Reviews in the neurosciences.

[170]  Hao Wu,et al.  Structural mechanisms of inflammasome assembly , 2015, The FEBS journal.

[171]  Rui Liu,et al.  Gastrodin Alleviates Cerebral Ischemic Damage in Mice by Improving Anti-oxidant and Anti-inflammation Activities and Inhibiting Apoptosis Pathway , 2015, Neurochemical Research.

[172]  Kang Zhang,et al.  Caspase-8 promotes NLRP1/NLRP3 inflammasome activation and IL-1β production in acute glaucoma , 2014, Proceedings of the National Academy of Sciences.

[173]  G. van Loo,et al.  Negative regulation of the NLRP3 inflammasome by A20 protects against arthritis , 2014, Nature.

[174]  Ziying Wang,et al.  NLRP3 Deficiency Ameliorates Neurovascular Damage in Experimental Ischemic Stroke , 2014, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[175]  D. Longo,et al.  Necroptosis. , 2014, The New England journal of medicine.

[176]  B. Stockwell,et al.  The role of iron and reactive oxygen species in cell death. , 2014, Nature Chemical Biology.

[177]  Peter E. Czabotar,et al.  Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy , 2013, Nature Reviews Molecular Cell Biology.

[178]  Xinling Liang,et al.  Necrostatin-1 Attenuates Ischemia Injury Induced Cell Death in Rat Tubular Cell Line NRK-52E through Decreased Drp1 Expression , 2013, International journal of molecular sciences.

[179]  Toru Okamoto,et al.  The pseudokinase MLKL mediates necroptosis via a molecular switch mechanism. , 2013, Immunity.

[180]  Guohong Li,et al.  Role of Inflammation and Its Mediators in Acute Ischemic Stroke , 2013, Journal of Cardiovascular Translational Research.

[181]  R. Lockey,et al.  NLRP3 deletion protects from hyperoxia-induced acute lung injury. , 2013, American journal of physiology. Cell physiology.

[182]  K. Schroder,et al.  AIM2 and NLRP3 inflammasomes activate both apoptotic and pyroptotic death pathways via ASC , 2013, Cell Death and Differentiation.

[183]  S. Fulda.  Alternative Cell Death Pathways and Cell Metabolism , 2013, International journal of cell biology.

[184]  Wen Gao,et al.  Identification of metabolites of Buyang Huanwu decoction in rat urine using liquid chromatography-quadrupole time-of-flight mass spectrometry. , 2012, Journal of pharmaceutical and biomedical analysis.

[185]  M. Kyba,et al.  The H19 lincRNA is a developmental reservoir of miR-675 which suppresses growth and Igf1r , 2012, Nature Cell Biology.

[186]  Ann Chen,et al.  Lipopolysaccharide/adenosine triphosphate-mediated signal transduction in the regulation of NLRP3 protein expression and caspase-1-mediated interleukin-1β secretion , 2012, Inflammation Research.

[187]  Masaaki Komatsu,et al.  Autophagy: Renovation of Cells and Tissues , 2011, Cell.

[188]  Milos Pekny,et al.  The Role of Attenuated Astrocyte Activation in Infantile Neuronal Ceroid Lipofuscinosis , 2011, The Journal of Neuroscience.

[189]  D. Cacchiarelli,et al.  A Long Noncoding RNA Controls Muscle Differentiation by Functioning as a Competing Endogenous RNA , 2011, Cell.

[190]  A. Prathapan,et al.  ANTIOXIDANT AND ANTITHROMBOTIC ACTIVITY OF TENDER COCONUT WATER IN EXPERIMENTAL MYOCARDIAL INFARCTION , 2011 .

[191]  Brianne R. Barker,et al.  Cross-regulation between the IL-1β/IL-18 processing inflammasome and other inflammatory cytokines. , 2011, Current opinion in immunology.

[192]  G. Dubyak,et al.  Pannexin-1 Is Required for ATP Release during Apoptosis but Not for Inflammasome Activation , 2011, The Journal of Immunology.

[193]  J. Connor,et al.  Young coconut juice, a potential therapeutic agent that could significantly reduce some pathologies associated with Alzheimer's disease: novel findings , 2010, British Journal of Nutrition.

[194]  Jiye Zhang,et al.  Buyang Huanwu decoction ameliorates coronary heart disease with Qi deficiency and blood stasis syndrome by reducing CRP and CD40 in rats. , 2010, Journal of ethnopharmacology.

[195]  T. Billiar,et al.  Linking oxidative stress to inflammation: Toll-like receptors. , 2010, Free radical biology & medicine.

[196]  Richard Bonneau,et al.  Innate immune detection of the type III secretion apparatus through the NLRC4 inflammasome , 2010, Proceedings of the National Academy of Sciences.

[197]  W. Shao,et al.  The Caspase-1 Digestome Identifies the Glycolysis Pathway as a Target during Infection and Septic Shock*♦ , 2007, Journal of Biological Chemistry.

[198]  R. Böger.  The pharmacodynamics of L-arginine. , 2007, The Journal of nutrition.

[199]  W. Buczko,et al.  L-arginine and cardiovascular system. , 2005, Pharmacological reports : PR.

[200]  W. Buczko,et al.  Antithrombotic effect of L-arginine in hypertensive rats. , 2004, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[201]  John Calvin Reed,et al.  Fundamental role of the Rip2/caspase-1 pathway in hypoxia and ischemia-induced neuronal cell death , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[202]  J. Leonardi-Bee,et al.  Nitric oxide donors (nitrates), L-arginine, or nitric oxide synthase inhibitors for acute stroke. , 2002, The Cochrane database of systematic reviews.

[203]  Matthias Endres,et al.  Role of peroxynitrite and neuronal nitric oxide synthase in the activation of poly(ADP-ribose) synthetase in a murine model of cerebral ischemia-reperfusion , 1998, Neuroscience Letters.

[204]  M. Moskowitz,et al.  Ischemic Brain Injury is Mediated by the Activation of Poly(ADP-Ribose)Polymerase , 1997, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[205]  S. Snyder,et al.  Poly(ADP-ribose) polymerase gene disruption renders mice resistant to cerebral ischemia , 1997, Nature Medicine.

[206]  K. Nakayama,et al.  Identification and subcellular localization of a novel mammalian dynamin-related protein homologous to yeast Vps1p and Dnm1p. , 1997, Journal of biochemistry.